Clarity Raises $8,965,959.75. Opens the Capital Raise to External Investors
Sydney, Australia 18 February 2019 – Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that it has raised a total of $8,965,959.75. This includes the previously announced strategic investment of $5,000,002.75 from GenesisCare, the largest private provider of cancer treatment in Australia and Europe, and an additional $3,965,957.00…